Vaccine companies are striking deals with richer countries, leaving poorer countries on the sidelines.
Governments around the world racing to secure stock of potential coronavirus vaccines.
Britain will buy potential COVID-19 vaccines from U.S. drugmakers Johnson & Johnson <JNJ.N> and Novavax Inc <NVAX.O>, the companies said on Friday, boosting the number of deals it has with drugmakers as the global vaccine race rages on. Britain and the United States are in the lead with six vaccine deals with drugmakers each, as companies and governments worldwide work overtime to find a vaccine against the pandemic disease. The latest agreements bring Britain's total number of doses secured to 340 million, with options for millions more, for a population of 66 million.